Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression
/in Dendritic Cells, International Publications, Soft Tissue SarcomaHeat shock and heat shock protein 70i enhance the oncolytic effect of replicative adenovirus
/in Hyperthermia, International Publications, Newcastle Disease VirusEffective treatment of small murine hepatocellular carcinoma by dendritic cells
/in Hepatocellular Carcinoma, International PublicationsNewcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration
/in International Publications, Newcastle Disease VirusImmunotherapy for medullary thyroid carcinoma by dendritic cell vaccination
/in Dendritic Cells, International Publications, Thyroid CancerResults of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
/in Dendritic Cells, Glioblastoma, International PublicationsTumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines
/in International Publications, Pancreatic CancerEffect of whole body hyperthermia on radiation therapy of transplanted fibrosarcoma in Swiss mice
/in Hyperthermia, International Publications, Soft Tissue Sarcoma
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer